Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-01-14 @ 7:24 PM
Study NCT ID:
NCT01556035
Status:
COMPLETED
Last Update Posted:
2016-09-23
First Post:
2012-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma
Sponsor:
University Hospital, Bordeaux
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) | View |